David Hilton-Jones

• Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.

  Figueroa-Bonaparte S. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 680 - 681

• A novel quantitative assay of mitophagy: Combining high content fluorescence microscopy and mitochondrial DNA load to quantify mitophagy and identify novel pharmacological tools against pathogenic heteroplasmic mtDNA.

  Diot A. et al, (2015), Pharmacol Res, 100, 24 - 35

• Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland

  Bansagi B. et al, (2015), Journal of Neurology, 262, 1899 - 1908

• Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.

  Bansagi B. et al, (2015), J Neurol, 262, 1899 - 1908

• Myasthenia gravis: Association of British Neurologists' management guidelines.

  Sussman J. et al, (2015), Pract Neurol, 15, 199 - 206

• Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

  Rodríguez Cruz PM. et al, (2015), JAMA Neurol, 72, 642 - 649

• Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

  Benveniste O. et al, (2015), Acta Neuropathologica, 129, 611 - 624

• Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.

  Benveniste O. et al, (2015), Acta Neuropathol, 129, 611 - 624

• Adult onset limb-girdle muscular dystrophy - A recessive titinopathy masquerading as myositis

  Dabby R. et al, (2015), Journal of the Neurological Sciences, 351, 120 - 123

• Adult onset limb-girdle muscular dystrophy - a recessive titinopathy masquerading as myositis.

  Dabby R. et al, (2015), J Neurol Sci, 351, 120 - 123

• The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.

  Gang Q. et al, (2015), Neurobiol Aging, 36, 1766.e1 - 1766.e3

• 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands.

  De Bleecker JL. et al, (2015), Neuromuscul Disord, 25, 268 - 272

• 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands

  De Bleecker JL. et al, (2015), Neuromuscular Disorders, 25, 268 - 272

• The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis

  Gang Q. et al, (2015), Neurobiology of Aging, 36, 1766.e1 - 1766.e3

• UK Facioscapulohumeral Muscular Dystrophy (FSHD) Patient Registry.

  Wood L. et al, (2014), Orphanet J Rare Dis, 9

• Myositis mimics: how to recognize them.

  Hilton-Jones D., (2014), Curr Opin Rheumatol, 26, 663 - 670

• Myotonic dystrophy: diagnosis, management and new therapies.

  Turner C. and Hilton-Jones D., (2014), Curr Opin Neurol, 27, 599 - 606

• Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathy.

  Lamont PJ. et al, (2014), Hum Mutat, 35, 868 - 879

• Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group.

  Norwood F. et al, (2014), J Neurol Neurosurg Psychiatry, 85, 538 - 543

• A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease.

  Graham CD. et al, (2014), Clin Rehabil, 28, 508 - 519

• A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.

  Brady S. et al, (2014), BMJ Open, 4

• Myotonic dystrophy: Diagnosis, management and new therapies

  Turner C. and Hilton-Jones D., (2014), Current Opinion in Neurology, 27, 599 - 606

• Myositis mimics: How to recognize them

  Hilton-Jones D., (2014), Current Opinion in Rheumatology, 26, 663 - 670

• Myasthenia in pregnancy: Best practice guidelines from a UK multispecialty working group

  Norwood F. et al, (2014), Journal of Neurology, Neurosurgery and Psychiatry, 85, 538 - 543

• MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011.

  Turner C. et al, (2013), Neuromuscul Disord, 23, 1069 - 1080

• MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011

  Turner C. et al, (2013), Neuromuscular Disorders, 23, 1069 - 1080

• Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

  Miller FW. et al, (2013), Arthritis Rheum, 65, 3239 - 3247

• Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.

  Jaffer F. et al, (2013), J Neurol Neurosurg Psychiatry, 84

• Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.

  Brady S. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 1240 - 1246

• ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation

  Sarkozy A. et al, (2013), Human Mutation, 34, 1111 - 1118

• ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.

  Sarkozy A. et al, (2013), Hum Mutat, 34, 1111 - 1118

• EFNS review on the role of muscle biopsy in the investigation of myalgia

  Kyriakides T. et al, (2013), European Journal of Neurology, 20, 997 - 1005

• EFNS review on the role of muscle biopsy in the investigation of myalgia.

  Kyriakides T. et al, (2013), Eur J Neurol, 20, 997 - 1005

• Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials

  Cortese A. et al, (2013), Neuromuscular Disorders, 23, 404 - 412

• Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.

  Cortese A. et al, (2013), Neuromuscul Disord, 23, 404 - 412

• Fracture rate in patients with myasthenia gravis: the general practice research database.

  Pouwels S. et al, (2013), Osteoporos Int, 24, 467 - 476

• Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features

  Brady S. et al, (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84, 1240 - 1246

• Myopathies in the adult patient

  Hilton-Jones D., (2012), Medicine (United Kingdom), 40, 558 - 565

• Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.

  Jacob S. et al, (2012), Arch Neurol, 69, 994 - 1001

• Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.

  Hilton-Jones D. et al, (2012), Neuromuscul Disord, 22, 597 - 603

• Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 - The patients' perspective

  Hilton-Jones D. et al, (2012), Neuromuscular Disorders, 22, 597 - 603

• Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

  Leite MI. et al, (2012), Neurology, 78, 1601 - 1607

• Muscle Disorders

  Hilton-Jones D., (2012), Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition, 1, 779 - 792

• Physical training for McArdle disease.

  Quinlivan R. et al, (2011), Cochrane Database Syst Rev

• Physical training for McArdle disease.

  Quinlivan R. et al, (2011), Cochrane database of systematic reviews (Online), 12

• Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation.

  Robinson DO. et al, (2011), Neuromuscul Disord, 21, 809 - 811

• Long-term observational study of sporadic inclusion body myositis.

  Benveniste O. et al, (2011), Brain, 134, 3176 - 3184

• Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.

  Sarkozy A. et al, (2011), Eur J Hum Genet, 19, 1038 - 1044

• Diagnostic Approach to Pauci-or Asymptomatic hyperCKemia

  Kyriakides T. et al, (2011), European Handbook of Neurological Management, 2, 279 - 286

• Neuromuscular Disorders in the Intensive Care Unit

  Damian MS. and Hilton-Jones D., (2011), Neuromuscular Disorders, 243 - 248

• Supported community exercise in people with long-term neurological conditions: a phase II randomized controlled trial.

  Elsworth C. et al, (2011), Clin Rehabil, 25, 588 - 598

• Response

  Hilton-Jones D., (2011), Neuromuscular Disorders, 21, 524 - 525

• The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.

  Maddison P. et al, (2011), J Neurol Neurosurg Psychiatry, 82, 671 - 673

• Observations on the classification of the inflammatory myopathies.

  Hilton-Jones D., (2011), Presse Med, 40, e199 - e208

• Observations on the classification of the inflammatory myopathies

  Hilton-Jones D., (2011), Presse Medicale, 40

• Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

  Titulaer MJ. et al, (2011), J Clin Oncol, 29, 902 - 908

• Oculopharyngodistal myopathy--a possible association with cardiomyopathy.

  Thevathasan W. et al, (2011), Neuromuscul Disord, 21, 121 - 125

• Authors' reply to BioMarin Europe

  Nicholl DJ. et al, (2011), BMJ, 342

• Long-term observational study of sporadic inclusion body myositis

  Benveniste O. et al, (2011), Brain, 134, 3176 - 3184

• The role of rituximab in the treatment of myasthenia gravis

  Benveniste O. and Hilton-Jones D., (2010), European Neurological Review, 5, 95 - 100

• Open letter to prime minister David Cameron and health secretary Andrew Lansley.

  Nicholl DJ. et al, (2010), BMJ, 341

• Autoimmune Neuromuscular Transmission Disorders

  Skeie GO. et al, (2010), European Handbook of Neurological Management: Second Edition, 1, 321 - 331

• Guidelines for treatment of autoimmune neuromuscular transmission disorders.

  Skeie GO. et al, (2010), Eur J Neurol, 17, 893 - 902

• International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009.

  Benveniste O. and Hilton-Jones D., (2010), Neuromuscul Disord, 20, 414 - 421

• EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia.

  Kyriakides T. et al, (2010), Eur J Neurol, 17, 767 - 773

• Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies

  Zimoń M. et al, (2010), Brain, 133, 1798 - 1809

• Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.

  Zimoń M. et al, (2010), Brain, 133, 1798 - 1809

• Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations.

  Tajsharghi H. et al, (2010), Brain, 133, 1451 - 1459

• Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations

  Tajsharghi H. et al, (2010), Brain, 133, 1451 - 1459

• The myotonic dystrophies: diagnosis and management.

  Turner C. and Hilton-Jones D., (2010), J Neurol Neurosurg Psychiatry, 81, 358 - 367

• Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008.

  Hilton-Jones D. et al, (2010), Neuromuscul Disord, 20, 142 - 147

• Open letter to prime minister David Cameron and health secretary Andrew Lansley.

  Nicholl DJ. et al, (2010), BMJ (Clinical research ed.), 341

• Myasthenia gravis and other neuromuscular junction disorders.

  Jacob S. et al, (2009), Pract Neurol, 9, 364 - 371

• In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.

  Shatunov A. et al, (2009), Eur J Hum Genet, 17, 656 - 663

• Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

  Schoser B. et al, (2009), Neuromuscul Disord, 19, 223 - 228

• A study of perceived facilitators to physical activity in neurological conditions

  Elsworth C. et al, (2009), International Journal of Therapy and Rehabilitation, 16, 17 - 23

• Caveolinopathy--new mutations and additional symptoms.

  Aboumousa A. et al, (2008), Neuromuscul Disord, 18, 572 - 578

• Approach to critical illness polyneuropathy and myopathy.

  Pati S. et al, (2008), Postgrad Med J, 84, 354 - 360

• Myopathy associated with statin therapy.

  Hilton-Jones D., (2008), Neuromuscul Disord, 18, 97 - 98

• Myasthenia gravis seronegative for acetylcholine receptor antibodies.

  Vincent A. et al, (2008), Ann N Y Acad Sci, 1132, 84 - 92

• When the patient fails to respond to treatment: myasthenia gravis.

  Hilton-Jones D., (2007), Pract Neurol, 7, 405 - 411

• A young man with rapidly progressive multifocal disease affecting the white matter.

  Hilton-Jones D. et al, (2007), Pract Neurol, 7, 172 - 181

• Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis

  Farrugia ME. et al, (2007), Clinical Neurophysiology, 118, 1174 - 1175

• Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.

  Farrugia ME. et al, (2007), Clin Neurophysiol, 118, 269 - 277

• Miscellaneous myopathies.

  Hilton-Jones D., (2007), Handb Clin Neurol, 86, 397 - 409

• Myotonic dystrophy: practical issues relating to assessment of strength.

  Whittaker RG. et al, (2006), J Neurol Neurosurg Psychiatry, 77, 1282 - 1283

• Myopathies in the older patient

  Hilton-Jones D. and Damian MS., (2006), Reviews in Clinical Gerontology, 16, 209 - 229

• Guidelines for the treatment of autoimmune neuromuscular transmission disorders.

  Skeie GO. et al, (2006), Eur J Neurol, 13, 691 - 699

• MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

  Farrugia ME. et al, (2006), Brain, 129, 1481 - 1492

• Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.

  Farrugia ME. et al, (2006), Muscle Nerve, 33, 568 - 570

• In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.

  Chinoy H. et al, (2006), Arthritis Res Ther, 8

• Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.

  Davies NP. et al, (2005), Neurology, 65, 1083 - 1089

• Clinical and molecular aspects of the myotonic dystrophies: a review.

  Machuca-Tzili L. et al, (2005), Muscle Nerve, 32, 1 - 18

• A swollen calf.

  Khan SY. et al, (2005), Lancet, 365

• The management of myasthenia gravis

  Hilton-Jones D. and Palace J., (2005), Practical Neurology, 5, 18 - 27

• Myasthenia gravis and Lambert-Eaton myasthenic syndrome

  Palace J. and Hilton-Jones D., (2004), Medicine, 32, 114 - 118

• [Pathogenesis of primary inflammatory myopathies].

  Benveniste O. et al, (2004), Presse Med, 33, 1444 - 1450

• Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I.

  Poppe M. et al, (2004), Ann Neurol, 56, 738 - 741

• Congenital muscular dystrophy with short stature, proximal contractures and distal laxity.

  Mercuri E. et al, (2004), Neuropediatrics, 35, 224 - 229

• Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy.

  Evgrafov OV. et al, (2004), Nat Genet, 36, 602 - 606

• Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy.

  Irobi J. et al, (2004), Nat Genet, 36, 597 - 601

• Beevor's sign

  Hilton-Jones D., (2004), Practical Neurology, 4, 176 - 177

• How good at neurology are you? (multiple letters) [2]

  Hilton-Jones D. and Goldsmith P., (2003), Practical Neurology, 3, 383 - 384

• Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

  Burke G. et al, (2003), Neurology, 61, 826 - 828

• Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin c-terminal alpha-helical segment.

  Dagvadorj A. et al, (2003), Muscle Nerve, 27, 669 - 675

• Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.

  Talbot K. et al, (2003), Neuromuscul Disord, 13, 357 - 364

• Diagnosis and treatment of inflammatory muscle diseases.

  Hilton-Jones D., (2003), J Neurol Neurosurg Psychiatry, 74 Suppl 2, ii25 - ii31

• The limb-girdle muscular dystrophies: genetic and phenotypic definition of a disputed entity.

  Wicklund MP. and Hilton-Jones D., (2003), Neurology, 60, 1230 - 1231

• Long-term management of blood pressure after stroke (multiple letters) [2]

  Hilton-Jones D. and Anderson C., (2003), Practical Neurology, 3, 61 - 62

• Three cases of androgen-dependent disease associated with myotonic dystrophy.

  Cooper SM. et al, (2003), J Eur Acad Dermatol Venereol, 17, 56 - 58

• Syncoilin accumulation in two patients with desmin-related myopathy.

  Howman EV. et al, (2003), Neuromuscul Disord, 13, 42 - 48

• Mitochondrial cytopathy

  Hilton-Jones D., (2002), Practical Neurology, 2, 55 - 57

• Inclusion body myositis

  Hilton-Jones D., (2002), Practical Neurology, 2, 294 - 297

• Diagnose myasthenia gravis

  Hilton-Jones D., (2002), Practical Neurology, 2, 173 - 177

• Desmin myopathy: Distinct filamentopathy caused by mutations in the desmin gene

  Dalakas MC. et al, (2002), Acta Myologica, 21, 138 - 143

• Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease.

  Lee MJ. et al, (2002), J Neurol Neurosurg Psychiatry, 73, 304 - 306

• Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: A quantitative ³¹P-magnetic resonance spectroscopy and MRI study

  Cea G. et al, (2002), Brain, 125, 1635 - 1645

• Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.

  Cea G. et al, (2002), Brain, 125, 1635 - 1645

• An expanded cortical representation for hand movement after peripheral motor denervation.

  Reddy H. et al, (2002), J Neurol Neurosurg Psychiatry, 72, 203 - 210

• McArdle's disease

  Hilton-Jones D., (2001), Practical Neurology, 1, 122 - 125

• Classification and diagnosis of myopathies - An update

  Hilton-Jones D., (2001), CPD Bulletin Neurology, 2, 71 - 74

• Myopathies

  Hilton-Jones D., (2001), Reviews in Clinical Gerontology, 11, 131 - 147

• Inflammatory muscle diseases.

  Hilton-Jones D., (2001), Curr Opin Neurol, 14, 591 - 596

• Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

  Clarke NR. et al, (2001), Heart, 86, 411 - 416

• Myasthenia gravis.

  Vincent A. et al, (2001), Lancet, 357, 2122 - 2128

• Oculopharyngeal muscular dystrophy phenotypic and genotypic studies in a UK population

  Hill ME. et al, (2001), Brain, 124, 522 - 526

• Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population.

  Hill ME. et al, (2001), Brain, 124, 522 - 526

• Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.

  Grain L. et al, (2001), Neuromuscul Disord, 11, 186 - 191

• Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy.

  Crilley JG. et al, (2000), J Am Coll Cardiol, 36, 1953 - 1958

• New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC).

  (2000), Neurology, 54, 1218 - 1221

• Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.

  Lodi R. et al, (1998), Brain, 121 ( Pt 11), 2119 - 2126

• Del(18p) shown to be a cryptic translocation using a multiprobe FISH assay for subtelomeric chromosome rearrangements.

  Horsley SW. et al, (1998), J Med Genet, 35, 722 - 726

• Myotonic dystrophy--forgotten aspects of an often neglected condition.

  Hilton-Jones D., (1997), Curr Opin Neurol, 10, 399 - 401

• Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy.

  Metzinger L. et al, (1997), Hum Mol Genet, 6, 1185 - 1191

• Spontaneous intracranial hypotension.

  Renowden SA. et al, (1995), J Neurol Neurosurg Psychiatry, 59, 511 - 515

• Death after ecstasy ingestion: neuropathological findings.

  Squier MV. et al, (1995), J Neurol Neurosurg Psychiatry, 58

• Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.

  Matthews PM. et al, (1995), Neuromuscul Disord, 5, 209 - 220

• Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother.

  Barnes PR. et al, (1995), Neuromuscul Disord, 5, 59 - 65

• Myopathies

  (1995), Reviews in Clinical Gerontology, 5, 275 - 288

• Incorrect diagnosis of myotonic dystrophy and its potential consequences revealed by subsequent direct genetic analysis.

  Barnes PR. et al, (1994), J Neurol Neurosurg Psychiatry, 57

• Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.

  Matthews PM. et al, (1994), J Med Genet, 31, 41 - 44

• Molecular genetics of myotonic dystrophy.

  Barnes PR. and Hilton-Jones D., (1993), Br J Hosp Med, 50

• Dystrophin-associated protein complex: clinical implications.

  Hilton-Jones D. and Squier MV., (1993), Lancet, 341, 528 - 529

• Risk of cancer in dermatomyositis or polymyositis.

  Hilton-Jones D. and Squier MV., (1992), N Engl J Med, 327

• Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.

  Squier M. et al, (1991), Muscle Nerve, 14, 625 - 632

• An unusual metabolic myopathy: a malate-aspartate shuttle defect.

  Hayes DJ. et al, (1987), J Neurol Sci, 82, 27 - 39

• The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy.

  Oberhaensli RD. et al, (1987), Br J Radiol, 60, 367 - 373

• A new metabolic myopathy: A malate-aspartate-shuttle effect

  Hayes DJ. et al, (1986), Biochemical Society Transactions, 14, 1208 - 1209

• Valproate toxicity and ornithine carbamoyltransferase deficiency.

  Kay JD. et al, (1986), Lancet, 2, 1283 - 1284

• Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

  Oberhaensli RD. et al, (1986), Lancet, 2, 8 - 11

• Myasthenic crisis precipitated by iodinated contrast agents.

  Hilton-Jones D., (1986), Neurology, 36

• P-31 magnetic resonance studies of human brain at 2 T

  Oberhaensli RD. et al, (1986), Magnetic Resonance Imaging, 4, 417 - 419

• A mitochondrial encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation.

  Hayes DJ. et al, (1985), J Neurol Sci, 71, 105 - 118

• Non-penetrating arterial trauma and cerebral infarction in the young.

  Hilton-Jones D. and Warlow CP., (1985), Lancet, 1, 1435 - 1438

• The causes of stroke in the young.

  Hilton-Jones D. and Warlow CP., (1985), J Neurol, 232, 137 - 143

• Motor neuron disease in England and Wales, 1959-1979.

  Buckley J. et al, (1983), J Neurol Neurosurg Psychiatry, 46, 197 - 205

• The significance of the incidental finding of basal ganglia calcification on computed tomography.

  Hilton-Jones D., (1982), J Neurol Neurosurg Psychiatry, 45, 942 - 943

• Transient visual obscurations, without papilloedema.

  Hilton-Jones D. et al, (1982), J Neurol Neurosurg Psychiatry, 45, 832 - 834

• Failure of postural manoeuvres to prevent lumbar puncture headache.

  Hilton-Jones D. et al, (1982), J Neurol Neurosurg Psychiatry, 45, 743 - 746

• Headache after lumbar puncture.

  Hilton-Jones D., (1981), Lancet, 2, 253 - 254

• Disorders of the neuromuscular junction

  Hilton-Jones, David None. and Palace J., Oxford Textbook of Medicine

Recent Publications

• Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.

  Figueroa-Bonaparte S. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 680 - 681

• A novel quantitative assay of mitophagy: Combining high content fluorescence microscopy and mitochondrial DNA load to quantify mitophagy and identify novel pharmacological tools against pathogenic heteroplasmic mtDNA.

  Diot A. et al, (2015), Pharmacol Res, 100, 24 - 35

• Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland

  Bansagi B. et al, (2015), Journal of Neurology, 262, 1899 - 1908

• Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.

  Bansagi B. et al, (2015), J Neurol, 262, 1899 - 1908

• Myasthenia gravis: Association of British Neurologists' management guidelines.

  Sussman J. et al, (2015), Pract Neurol, 15, 199 - 206